ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Neurology

Top Neurology Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MOOL NIGAM M.D.

Neurology

3,620

$277K

341
76 are 65+

49%
patients receiving schedule two controlled substances

Avg: 2%

65%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 28%

$77
Average prescription price

Avg: $218

INNAD HUSAINI MD

Neurology

2,169

$41.5K

249
52 are 65+

16%
patients receiving schedule two controlled substances

Avg: 2%

86%
patients receiving schedule three controlled substances

Avg: 5%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

2%
prescriptions for brand name drugs

Avg: 28%

$19
Average prescription price

Avg: $218

LILLY CHEN M.D.

Neurology

2,260

$201K

158
41 are 65+

35%
patients receiving schedule two controlled substances

Avg: 2%

80%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 28%

$89
Average prescription price

Avg: $218

RANJITKUMAR PATEL MD

Neurology

2,638

$156K

205
59 are 65+

22%
patients receiving schedule two controlled substances

Avg: 2%

76%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 28%

$59
Average prescription price

Avg: $218

BASEM HAMID MD

Neurology

4,636

$262K

482
289 are 65+

24%
patients receiving schedule two controlled substances

Avg: 2%

61%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 28%

$57
Average prescription price

Avg: $218

EVERTON EDMONDSON M.D.

Neurology

5,920

$724K

321
142 are 65+

57%
patients receiving schedule two controlled substances

Avg: 2%

43%
patients receiving schedule three controlled substances

Avg: 5%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 28%

$122
Average prescription price

Avg: $218

CHEOR KIM M.D.

Neurology

2,460

$109K

127
62 are 65+

11%
patients receiving schedule two controlled substances

Avg: 2%

54%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 28%

$44
Average prescription price

Avg: $218

PANKAJ SATIJA M.D.

Neurology

818

$73.6K

119
74 are 65+

41%
patients receiving schedule two controlled substances

Avg: 2%

33%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 28%

$90
Average prescription price

Avg: $218

STANTON MOLDOVAN M.D.

Neurology

264

$13.6K

54
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

59%
patients receiving schedule three controlled substances

Avg: 5%

20%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 28%

$51
Average prescription price

Avg: $218

DAALON ECHOLS M.D.

Neurology

4,031

$426K

375
143 are 65+

26%
patients receiving schedule two controlled substances

Avg: 2%

49%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 28%

$106
Average prescription price

Avg: $218

LEE POLLACK MD

Neurology

6,570

$903K

280
133 are 65+

36%
patients receiving schedule two controlled substances

Avg: 2%

44%
patients receiving schedule three controlled substances

Avg: 5%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 28%

$137
Average prescription price

Avg: $218

PIERRE HERDING M.D.

Neurology

404

$22.4K

59
12 are 65+

22%
patients receiving schedule two controlled substances

Avg: 2%

51%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 28%

$56
Average prescription price

Avg: $218

CRAIG DUBOIS M.D.

Neurology

442

$34.2K

37
18 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

43%
patients receiving schedule three controlled substances

Avg: 5%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 28%

$77
Average prescription price

Avg: $218

CHRIS VICENTE M.D.

Neurology

717

$45.4K

121
48 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

51%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 28%

$63
Average prescription price

Avg: $218

WILLIAM TOBLEMAN MD

Neurology

1,929

$185K

126
80 are 65+

33%
patients receiving schedule two controlled substances

Avg: 2%

36%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 28%

$96
Average prescription price

Avg: $218

JONATHAN WALKER M.D.

Neurology

948

$100K

93
36 are 65+

19%
patients receiving schedule two controlled substances

Avg: 2%

38%
patients receiving schedule three controlled substances

Avg: 5%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 28%

$105
Average prescription price

Avg: $218

DANNY BARTEL M.D.

Neurology

11,216

$1.69M

953
453 are 65+

12%
patients receiving schedule two controlled substances

Avg: 2%

44%
patients receiving schedule three controlled substances

Avg: 5%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 28%

$151
Average prescription price

Avg: $218

MOHAMMED ATHARI M.D.

Neurology

5,483

$490K

399
223 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

29%
patients receiving schedule three controlled substances

Avg: 5%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 28%

$89
Average prescription price

Avg: $218

JOHN CLAUDE KRUSZ PHD, MD

Neurology

2,095

$399K

106
35 are 65+

24%
patients receiving schedule two controlled substances

Avg: 2%

24%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 28%

$190
Average prescription price

Avg: $218

JAMSHID LOTFI MD

Neurology

666

$54.6K

98
45 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

34%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 28%

$82
Average prescription price

Avg: $218

JOSE MATUS MD

Neurology

7,065

$1.14M

549
260 are 65+

20%
patients receiving schedule two controlled substances

Avg: 2%

28%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 28%

$161
Average prescription price

Avg: $218

EVERETT HEINZE MD

Neurology

2,557

$218K

200
135 are 65+

14%
patients receiving schedule two controlled substances

Avg: 2%

25%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 28%

$85
Average prescription price

Avg: $218

GRZEGORZ KURZYDLO M.D., P.A.

Neurology

1,647

$151K

185
88 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

38%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 28%

$92
Average prescription price

Avg: $218

PAMELA BLAKE MD

Neurology

620

$78K

78
47 are 65+

23%
patients receiving schedule two controlled substances

Avg: 2%

27%
patients receiving schedule three controlled substances

Avg: 5%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 28%

$126
Average prescription price

Avg: $218

STEVEN INBODY M.D.

Neurology

793

$54.6K

47
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

26%
patients receiving schedule three controlled substances

Avg: 5%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 28%

$69
Average prescription price

Avg: $218

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank